Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new study-record version was submitted on November 11, 2026, and posted on November 12, 2026, updating the study status.
    Difference
    0.0%
    Check dated 2026-11-14T19:14:38.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A new study-record version dated October 26, 2026, records updates to the study status and its contacts and locations.
    Difference
    0.0%
    Check dated 2026-10-31T19:09:06.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The clinical trial record was updated with changes to its study status and contacts/locations, and a new version was added to its history.
    Difference
    0.1%
    Check dated 2026-10-24T19:00:22.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-17T20:51:17.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-10T21:49:38.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    New study-record versions dated September 26 and September 30, 2026, are listed, with updates to study status and contacts/locations. The September 21 date no longer appears in the history.
    Difference
    0.1%
    Check dated 2026-10-03T20:51:22.000Z thumbnail image

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.